Delcath Announces Proposed Public Offering Of Common Stock And Warrants

Delcath Systems, Inc. DCTH today announced its intention to offer, subject to market and other conditions, shares of its common stock and warrants to purchase shares of common stock in an underwritten public offering. Delcath also expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock and warrants offered in the public offering to cover over-allotments, if any. The proceeds of the offering will primarily be used for general corporate purposes, including, but not limited to, commercialization of our products, obtaining regulatory approvals, funding of our clinical trials, research, capital expenditures and working capital.